Steve Schonfeld’s Stoke Therapeutics STOK Stock Holding History

Steve Schonfeld’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.34M	Buy	102,229 +52,927	+107%	+$1.7M	0.01%	810
2026 Q1	$1.61M	Sell	49,302 -13,807	-22%	-$453K	0.01%	907
2025 Q4	$2M	Sell	63,109 -174,906	-73%	-$5.26M	0.01%	875
2025 Q3	$5.59M	Buy	238,015 +63,301	+36%	+$1.08M	0.03%	549
2025 Q2	$1.98M	Sell	174,714 -160,646	-48%	-$1.53M	0.01%	996
2025 Q1	$2.23M	Buy	335,360 +43,565	+15%	+$406K	0.01%	918
2024 Q4	$3.22M	Buy	+291,795	New	+$3.58M	0.02%	648
2023 Q3	–	Sell	-62,902	Closed	-$669K	–	2270
2023 Q2	$669K	Buy	+62,902	New	+$669K	0.01%	1116

Other funds holding STOK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steve Schonfeld's STOK Position: Q2 2026 in Review

Steve Schonfeld increased its Stoke Therapeutics (STOK) stake by 107% in Q2 2026, buying an estimated $1.7M and bringing the position to 102,229 shares worth $3.34M. The position accounts for 0.01% of the portfolio, ranked #810.

Steve Schonfeld first reported a position in STOK in Q2 2023 and has held it in 8 quarters since. The position peaked at $5.59M in Q3 2025. 196 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

Steve Schonfeld held 102,229 shares of Stoke Therapeutics worth $3.34M as of Q2 2026.
Steve Schonfeld bought 52,927 Stoke Therapeutics shares in Q2 2026, an estimated $1.7M.
Stoke Therapeutics made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #810 holding.
Steve Schonfeld first reported a position in Stoke Therapeutics in Q2 2023 and has held it in 8 quarters since.
Steve Schonfeld's Stoke Therapeutics position peaked at $5.59M in Q3 2025.
196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.